Otherscore 1137·9 metrosupdated 9h ago

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest step by the

Where it's breaking

Local coverage

Sources cited

Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.

What this is

A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.